MedTrace Logo

Multimodal Therapy Impact on Pancreatic Cancer Survival

NCT06938906 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 405

Last updated 2025-04-24

No results posted yet for this study

Summary

The goal of this retrospective cohort study is to analyze change of treatment strategies affect the survival outcomes in patients of pancreatic cancer who received curative-intent treatment. The main question it aims to answer is:

Hypothesis: Change of treatment strategies involving increased utility of neoadjuvant chemotherapy and aggressive surgical approaches of extended pancreatectomy improved the overall and progression free survival in the patients with pancreatic cancer.

Participants received curative treatment for pancreatic cancer.

Conditions

Sponsors & Collaborators

  • National Cheng Kung University

    lead OTHER

Principal Investigators

  • Yan-Shen Shan, MD., PhD. · Department of Surgery, National Cheng Kung University Hospital

  • Ting-Kai Liao, MD. · National Cheng-Kung University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-03
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06938906 on ClinicalTrials.gov